Estrogen deficiency is well recognized as a cause of bone loss in rats
and humans. Likewise, treatment with estrogen results in prevention o
f this loss. Initially, this effect was thought to be indirectly media
ted but, more recently, estrogen receptors (ER) have been reported in
osteosarcoma cells and primary cultures originating from surgical wast
e, suggesting a direct effect of this steroid hormone. Detection of ER
in skeletal tissues, however, has remained elusive. The purpose of th
is investigation was to establish the efficacy of the highly sensitive
reverse-transcription polymerase chain reaction (RT-PCR) technique to
detect ER in a well defined skeletal tissue (calvarial periosteum) th
at is responsive to the hormone. Primers were made specific to rat ER
sequences. Total RNA was extracted from rat uterus, liver, spleen, and
the periosteum using an organic solvent method. cDNA was synthesized
from 2 mu g total RNA. cDNA corresponding to 40 ng total RNA/sample pr
oduced intense PCR products for ER. In descending order of intensity w
ere uterus, liver, bone, and spleen. Importantly, a similar time-cours
e for estrogen-induced down-regulation of steady-state mRNA levels for
alkaline phosphatase and osteonectin was observed in calvarial perios
teum and tissues known to express estrogen receptors. These data provi
de in vivo evidence of ER mRNA in bone and suggest that at least some
of estrogen's action on bone is directly modulated.